Aluminum exposure through the diet: Metal levels in AβPP transgenic mice, a model for Alzheimer's disease

Toxicology

Volumn 249, Issue 2-3, 2008, Pages 214-219

  Gómez, Mercedes ^a   Esparza, José L ^a   Cabré, María ^a   García, Tania ^a   Domingo, José L ^a  

^a UNIVERSITAT ROVIRA I VIRGILI   (Spain)

Author keywords

A PP transgenic mice; Aluminum; Copper; Dietary exposure; Iron; Manganese; Zinc

Indexed keywords

ALUMINUM; AMYLOID BETA PROTEIN; COPPER; IRON; MANGANESE; ZINC;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CEREBELLUM; CONTROLLED STUDY; DIETARY INTAKE; FEMALE; GENOTYPE; HIPPOCAMPUS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; WEIGHT GAIN;

ALUMINUM; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BRAIN; DIET; FEMALE; HUMANS; MALE; METALS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PREGNANCY; TISSUE DISTRIBUTION;

ANIMALIA; MUS; MUS MUSCULUS;

EID: 46249093889     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2008.05.004     Document Type: Article

References (57)

1. Atwood C.S., Huang X., Moir R.D., Tanzi R.E., and Bush A.I. Role of free radicals and metals ions in the pathogenesis of Alzheimer's disease. Metal Ions Biol. Syst. 36 (1999) 309-364
2. Bartzokis G., Beckson M., Hance D.B., Marx P., Foster J.A., and Marder S.R. MR evaluation of age-related increase of brain iron in young adult and older normal males. Magn. Reson. Imaging 15 (1997) 29-35
3. Becaria A., Campbell A., and Bondy S.C. Aluminum and copper interact in the promotion of oxidative but not inflammatory events: implications for Alzheimer's disease. J. Alzheimers Dis. 5 (2003) 31-38
4. Becaria A., Lahiri D.K., Bondy S.C., Chen D., Hamadeh A., Li H., Taylor R.T., and Campbell A. Aluminum and copper in drinking water enhance inflammatory or oxidative events specifically in the brain. J. Neuroimag. 176 (2006) 16-23
5. Bondy S.C., and Kirstein S. The promotion of iron-induced generation of reactive oxygen species in nerve tissue by aluminum. Mol. Chem. Neuropathol. 27 (1996) 185-194
6. Bondy S.C., Guo-Ross S.X., and Truong A.T. Promotion of transition metal-induced reactive oxygen species formation by beta-amyloid. Brain Res. 799 (1998) 91-96
7. Bush A.I. The metallobiology of Alzheimer's disease. Trends Neurosci. 26 (2003) 207-214
8. Campbell A. Inflammation, neurodegenerative diseases, and environmental exposures. Ann. NY Acad. Sci. 1035 (2004) 117-132
9. Chapman P.F., White G.L., Jones M.W., Cooper-Blacketer D., Marshall V.J., Irizarry M., Younkin L., Good M.A., Bliss T.V., Hyman B.T., Younkin S.G., and Hsiao K.K. Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice. Nat. Neurosci. 2 (1999) 271-276
10. Colomina M.T., Roig J.L., Torrente M., Vicens P., and Domingo J.L. Concurrent exposure to aluminum and stress during pregnancy in rats: effects on postnatal development and behavior of the offspring. Neurotoxicol. Teratol. 27 (2005) 565-574
11. Domingo J.L., Llorens J., Sanchez D.J., Gomez M., Llobet J.M., and Corbella J. Age-related effects of aluminum ingestion on brain aluminum accumulation and behavior in rats. Life Sci. 58 (1996) 1387-1395
12. Domingo J.L. Aluminum and other metals in Alzheimer's disease: a review of potential therapy with chelating agents. J. Alzheimers Dis. 10 (2006) 331-341
13. Donnelly P.S., Xiao Z., and Wedd A.G. Copper and Alzheimer's disease. Curr. Opin. Chem. Biol. 11 (2007) 128-133
14. Esparza J.L., Gomez M., Domingo J.L., Llobet J.M., and Corbella J. Element variation following chelation therapy in young and old aluminum-loaded rats. In: Centeno J.A., Collery Ph., Vernet G., Finkelman R.B., Gibb H., and Etienne J.C. (Eds). Metal Ions in Biology and Medicine vol. 6 (2000), John Libbey Eurotext, Paris 594-596
15. Esparza J.L., Gómez M., Romeu M., Mulero M., Sánchez D.J., Mallol J., and Domingo J.L. Aluminum-induced pro-oxidant effects in rats: protective role of exogenous melatonin. J. Pineal Res. 35 (2003) 32-39
16. Esparza J.L., Gomez M., Nogues M.R., Paternain J.L., Mallol J., and Domingo J.L. Melatonin reduces oxidative stress and increases gene expression in the cerebral cortex and cerebellum of aluminum exposed-rats. J. Pineal Res. 39 (2005) 129-136
17. Exley C. The pro-oxidant activity of aluminum. Free Radic. Biol. Med. 36 (2004) 380-387
18. Exley C., and Esiri M.M. Severe cerebral congophilic angiophaty coincident with increased brain aluminum in a resident of Camelford, Cornwall, UK. J. Neurol. Neurosurg. Psychiatry 77 (2006) 877-879
19. Flaten T.P. Aluminium as a risk factor in Alzheimer's disease, with emphasis on drinking water. Brain Res. Bull. 55 (2001) 187-196
20. Frautschy S.A., Yang F., Irizarry M., Hyman B., Daid T.C., Hsiao K., and Cole G.M. Microglial response to amyloid plaques in APP transgenic mice. Am. J. Pathol. 152 (1998) 307-317
21. Golub M.S., and Keen C.L. Effects of dietary aluminum on pubertal mice. Neurotoxicol. Teratol. 21 (1999) 595-602
22. Golub M.S., Germann S.L., Han B., and Keen C.L. Lifelong feeding of a high aluminum diet to mice. Toxicology 150 (2000) 107-117
23. Golub M.S., Germann S.L., and Keen C.L. Developmental aluminum toxicity in mice can be modulated by low concentrations of minerals (Fe, Zn, P, Ca, Mg) in the diet. Biol. Trace Elem. Res. 93 (2003) 213-226
24. Gómez M., Esparza J.L., Domingo J.L., Singh P.K., and Jones M.M. Chelation therapy in aluminum-loaded rats: influence of age. Toxicology 137 (1999) 161-168
25. Gómez M., Esparza J.L., Nogués M.R., Giralt M., and Domingo J.L. Pro-oxidant activity of aluminum in the rat hippocampus: gene expression of antioxidant enzymes after melatonin administration. Free Radic. Biol. Med. 38 (2005) 104-111
26. Hsiao K., Chapman P., Nilsen S.A., Eckman C., Harigaya Y., Younkin S., Yang F., and Cole G.M. Correlative memory deficits, Aβ elevation and amyloid plaques in transgenic mice. Science 174 (1996) 99-102
27. Huang X., Moir R.D., Tanzi R.E., Bush A.I., and Rogers J.T. Redox-active metals, oxidative stress, and Alzheimer's disease pathology. Ann. NY Acad. Sci. 1012 (2004) 153-163
28. Kawahara M. Effects of aluminum on the nervous system and its possible link with neurodegenerative diseases. J. Alzheimers Dis. 8 (2005) 171-182
29. Klevay L.M. Alzheimer's disease as copper deficiency. Med. Hypotheses 70 (2008) 802-807
30. Kowalik-Jankowska T., Ruta-Dolejsz M., Wisniewska K., Lankiewicz L., and Kozlowki H. Possible involvement of copper [II] in Alzheimer' disease. Environ. Health Perspect. 110 (2002) 869-870
31. Liu G., Huang W., Moir R.D., Vanderburg C.R., Lai B., Peng Z., Tanzi R.E., Rogers J.T., and Huang X. Metal exposure and Alzheimer's pathogenesis. J. Struct. Biol. 155 (2006) 45-51
32. López-Toledano M.A., and Shelanski M.L. Increased neurogenesis in young transgenic mice overexpressing human APP (Sw, Ind). J. Alzheimers Dis. 12 (2007) 229-240
33. Lovell M.A., Robertson J.D., Teesdale W.J., Campbell J.L., and Markesbery W.R. Copper, iron and zinc in Alzheimer's disease senile plaques. J. Neurol. Sci. 158 (1998) 47-52
34. Maynard C.J., Cappi R., Volitakis I., Cherny R.A., White A.R., Beyreuther K., Masters C.L., and Bush A.I. Overexpression of Alzheimer's disease amyloid-β opposes the age-dependent elevations of brain copper and iron. J. Biol. Chem. 277 (2002) 44670-44676
35. Maynard C.J., Bush A.I., Masters C.L., Cappai R., and Li Q.X. Metals and amyloid-β in Alzheimer' disease. Int. J. Exp. Pathol. 86 (2005) 147-159
36. Maynard C.J., Cappai R., Volitakis I., Cherny R.A., Masters C.L., Li Q.X., and Bush A.I. Gender and genetic background effects on brain metal levels in APP transgenic and normal mice: implications for Alzheimer beta-amyloid pathology. J. Inorg. Biochem. 100 (2006) 952-962
37. McLachlan D.R., Lukiw W.J., and Kruck T.P. New evidence for an active role of aluminium in Alzheimer' disease. Can. J. Neurol. Sci. 16 (1989) 490-497
38. McLachlan D.R., Kruck T.P., Lukiw W.J., and Krishnan S.S. Would decreased aluminium ingestion reduce the incidence of Alzheimer' disease?. CMAJ 145 (1991) 793-804
39. Milatovic D., Yin Z., Gupta R.C., Sidoryk M., Albrecht J., Aschner J.L., and Aschner M. Manganese induces oxidative impairment in cultured rat astrocytes. Toxicol. Sci. 98 (2007) 198-205
40. Morita A., Kimura M., and Itokawa Y. The effect of aging on the mineral status of female mice. Biol. Trace Elem. Res. 42 (1994) 165-177
41. Newman M., Musgrave F.I., and Lardelli M. Alzheimer disease: amyloidogenesis, the presenilins and animal models. BBA 1772 (2007) 285-297
42. Perl D.P., and Olanow C.W. The neuropathology of manganese-induced Parkinsonism. J. Neuropathol. Exp. Neurol. 66 (2007) 657-6822
43. Pratico D., Clark C.M., Liun F., Rokach J., Lee V.Y., and Trojanowski J.Q. Increase of brain oxidative stress in mild impairment: a possible predictor of Alzheimer's disease. Arch. Neurol. 59 (2002) 972-976
44. Pratico D., Uryu K., Sung S., Tang S., Trojanowski J.Q., and Lee V.M.Y. Aluminum modulates brain amyloidosis through oxidative stress in APP transgenic mice. FASEB J. 16 (2002) 1138-1140
45. Rao K.S.J., Rao R.V., Shanmugavelu P., and Menon R.B. Trace elements in Alzheimer's disease brain: a new hypothesis. Alzheimer's Rep. 2 (1999) 241-246
46. Religa D., Strozyk D., Cherny R.A., Volitakis I., Haroutunian V., Winblad B., Naslund J., and Bush A.J. Elevated cortical zinc in Alzheimer' disease. Neurology 67 (2006) 69-75
47. Rodrigo J., Fernandez-Vizcarra P., Castro-Blanco S., Bentura M.L., Nieto M., Gomez-Isla T., Martinez-Murillo R., Martinez A., Serrano J., and Fernandez A.P. Nitric oxide in the cerebral cortex of amyloid-precursor protein (SW) Tg 2576 transgenic mice. Neuroscience 128 (2004) 73-89
48. Shcherbatykh I., and Carpenter D.O. The role of metals in the etiology of Alzheimer's disease. J. Alzheimers Dis. 11 (2007) 191-205
49. Sparks D.L., and Schreurs B.G. Trace amounts of copper in water induce beta-amyloid plaques and learning deficits in a rabbit model of Alzheimer's disease. Proc. Natl. Acad. Sci. 100 (2003) 11065-11069
50. Strong M.J. Aluminum neurotoxicity; an experimental approach to the induction of neurofilamentous inclusions. J. Neuro Sci. 124 (1994) 125-131
51. Takeda A. Manganese action in brain function. Brain Res. Brain Res. Rev. 41 (2003) 79-87
52. Torrente M., Colomina M.T., and Domingo J.L. Behavioral effects of adult rats concurrently exposed to high doses of oral manganese and restraint stress. Toxicology 211 (2005) 59-69
53. Walton J.R. An aluminium-based rat model for Alzheimer's disease exhibits oxidative damage, inhibition of PP2A activity, hyperphosphorylated tau, and granulovacuolar degeneration. J. Inorg. Biochem. 101 (2007) 1275-1284
54. World Health Organization WHO/IPCS, 1997. Aluminum Environ. Health Criteria WHO 194, Geneva, pp. 1-152.
55. Yokel R.A. The toxicology of aluminum in the brain: a review. Neurotoxicology 21 (2000) 813-828
56. Yokel R.A. Blood-brain barrier flux of aluminum, manganese, iron and other metals suspected to contributed to metal-induced neurodegeneration. J. Alzheimers Dis. 10 (2006) 223-253
57. Yokel R.A., and Florence R.L. Aluminum bioavailability from the approved food additive leavening agent acid sodium aluminum phosphate, incorporated in to a baked good, is lower than from water. Toxicology 227 (2006) 86-93